Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor

REFERENCES

• Kohler B, Sherman R, Howlader N, Jemal A, Ryerson A, Henry K, Boscoe F, Cronin K, LAke A, Noon A, Henley S, Eheman C, Anderson R, Penberthy L. 2015. Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst 107:1–26.
   Google Scholar
• Gocheva V, Zeng W, Ke D, Kilimstra D, Reinheckel T, Peters C, Hanahan D, Joyce J. 2006. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev 20:543–556. https://doi.org/10.1101/gad.1407406.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Han M, Wang W, Song Y, Chen G, Wang Z, Liang Z. 2015. Downregulation of cathepsin L suppresses cancer invasion and migration by inhibiting transforming growth factor-β-mediated epithelial-mesenchymal transition. Oncol Rep 33:1851–1859. https://doi.org/10.3892/or.2015.3754.
   PubMed Web of Science ®Google Scholar
• Sullivan S, Tosetto M, Devans D, Coss A, Wang L, O'Donoghue D, Hyland J, Sheahan K, Mucahy H, O'Sullivan J. 2009. Localization of nuclear cathepsin L and its association with disease progression and poor outcome in clorectal cancer. Int J Cancer 125:54–61. https://doi.org/10.1002/ijc.24275.
   PubMedGoogle Scholar
• Grotsky DA, Gonzalez-Suarez I, Novell A, Neumann MA, Yaddanapudi SC, Croke M, Marinez-Alonso M, Redwood AB, Ortega-Martinez S, Feng Z, Lerma E, Ramon y Cajal T, Zhang J, Matias-Guiu X, Dusso A, Gonzalo S. 2013. BRCA1 loss activates cathepsin L-mediated degradation of 53BP1 in breast cancer cells. J Cell Biol 200:187–202. https://doi.org/10.1083/jcb.201204053.
   PubMed Web of Science ®Google Scholar
• Goulet B, Baruch A, Moon N, Poirier M, Sansregret L, Erickson A, Bogyo M, Nepveu A. 2004. A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor. Mol Cell 14:207–219. https://doi.org/10.1016/S1097-2765(04)00209-6.
   PubMed Web of Science ®Google Scholar
• Kedinger V, Sansregret L, Harada R, Vadnals C, Cadieux C, Fathers K, Park M, Nepveu A. 2009. p110 CUX1 homeodomain protein stimulates cell migration and invasion in part through a regulatory cascade culminating in the repression of E-cadherin and occludin. J Biol Chem 284:27701–27711. https://doi.org/10.1074/jbc.M109.031849.
   PubMed Web of Science ®Google Scholar
• Goulet B, Truscott M, Nepveu A. 2006. A novel proteolytically processed CDP/Cux isoform of 90 kDa is generated by cathepsin L. Biol Chem 387:1285–1293.
   PubMedGoogle Scholar
• Burton L, Smith B, Smith B, Loyd Q, Nagappan P, McKeithen D, Wilder C, Platt M, Hudson TS, Odero-Marah V. 2015. Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells. Carcinogenesis 36:1019–1027. https://doi.org/10.1093/carcin/bgv084.
   PubMed Web of Science ®Google Scholar
• Kalluri R, Weinberg R. 2009. The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420–1428. https://doi.org/10.1172/JCI39104.
   PubMed Web of Science ®Google Scholar
• Dang H, Ding W, Emerson D, Rountree CB. 2011. Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics. BMC Cancer 11:396–409. https://doi.org/10.1186/1471-2407-11-396.
   PubMedGoogle Scholar
• Palermo C, Joyce J. 2008. Cysteine cathepsin proteases as pharmacological targets in cancer. Trends Pharmacol Sci 29:22–28. https://doi.org/10.1016/j.tips.2007.10.011.
   PubMed Web of Science ®Google Scholar
• Siklos M, BenAissa M, Thatcher G. 2015. Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors. Acta Pharm Sin B 5:506–519. https://doi.org/10.1016/j.apsb.2015.08.001.
   PubMed Web of Science ®Google Scholar
• Tamhane T, Illukkumbura R, Lu S, Maelandsmo G, Haugen M, Brix K. 2016. Nuclear cathepsin L activity is required for cell cycle progression of colorectal carcinoma cells. Biochimie 122:208–218. https://doi.org/10.1016/j.biochi.2015.09.003.
   PubMedGoogle Scholar
• Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC. 2004. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6:931–940. https://doi.org/10.1038/ncb1173.
   PubMed Web of Science ®Google Scholar
• Goulet B, Sansregret L, Leduy L, Bogyo M, Weber E, Chauhan SS, Nepveu A. 2007. Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation. Mol Cancer Res 5:899–907. https://doi.org/10.1158/1541-7786.MCR-07-0160.
   PubMed Web of Science ®Google Scholar
• Chavez KJ, Garimella SV, Lipkowitz S. 2010. Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer. Breast Dis 32:35–48. https://doi.org/10.3233/BD-2010-0307.
   PubMedGoogle Scholar
• Truscott M, Raynal L, Premdas P, Goulet B, Leduy L, Berube G, Nepyeu A. 2003. CDP/Cux stimulates transcription from the DNA polymerase α gene promoter. Mol Cell Biol 23:3013–3028. https://doi.org/10.1128/MCB.23.8.3013-3028.2003.
   PubMedGoogle Scholar
• Zhang Q, Wang W, Li J, Yang N, Chen G, Wang Z, Liang Z. 2015. Cathepsin L suppression increases the radiosensitivity of human glioma U251 cells via G2/M cell cycle arrest and DNA damage. Acta Pharm Sin B 36:1113–1125. https://doi.org/10.1038/aps.2015.36.
   Google Scholar
• Smith BN, Burton LJ, Henderson V, Randle DD, Morton DJ, Smith BA, Taliaferro-Smith L, Nagappan P, Yates C, Zayzafoon M, Chung LW, Odero-Marah VA. 2014. Snail promotes epithelial mesenchymal transition in breast cancer cells in part via activation of nuclear ERK2. Plos One 9:e104987. https://doi.org/10.1371/journal.pone.0104987.
   Google Scholar
• Wilder C, Park K, Keegan P, Platt M. 2011. Manipulating substrate and pH in zymography protocols selectively distinguishes cathepsins K, L, S and V activity in cells and tissues. Arch Biochem Biophys 516:187–202.
   Google Scholar